Detecting drug interactions using personal digital assistants in an out-patient clinic

QJM: An International Journal of Medicine

Volumn 100, Issue 11, 2007, Pages 691-697

  Dallenbach, M Francis ^a   Bovier, Patrick A ^a   Desmeules, J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CISAPRIDE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; ERGOTAMINE; FUROSEMIDE; HEPARIN; HYDROCHLOROTHIAZIDE; LITHIUM SALT; MEFENAMIC ACID; METHADONE; METHOTREXATE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLEPHRINE; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SCOPOLAMINE; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; WARFARIN;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DRUG COMPETITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; MEDICATION ERROR; OUTPATIENT CARE; PATIENT SAFETY; PERSONAL DIGITAL ASSISTANT; PHARMACEUTICAL CARE; PREDICTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REFERENCE DATABASE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 35848950918     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm088     Document Type: Article

References (34)

1. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW. Adverse drug events in ambulatory care. N Engl J Med 2003; 348:1556-64.
2. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2006; 63:136-47.
3. Wasserfallen J, Livio F, Buclin T, Jillet L, Yersin B, Biollaz J. Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med 2001; 12:442-7.
4. Morris CJ, Rodgers S, Hammersley VS, Avery AJ, Cantrill JA. Indicators for preventable drug related morbidity: Application in primary care. Qual Saf Health Care 2004; 13:181-5.
5. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: A prospective study. Ann Pharmacother 1999; 33:1252-7.
6. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277:307-11.
7. Olivier P, Boulbes O, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Assessing the feasibility of using an adverse drug reaction preventability scale in clinical practice: A study in a French emergency department. Drug Saf 2002; 25:1035-44.
8. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36:1238-48.
9. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31:199-205.
10. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, Stocker DN, Braunschweig S, Kullak-Ublick GA, Galeazzi RL, Follath F, Gasser T, Meier PJ. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49:158-67.
11. Linnarsson R. Drug interactions in primary health care. A retrospective database study and its implications for the design of a computerized decision support system. Scand J Prim Health Care 1993; 11 181-6.
12. Livio F. Hospitalisation pour effet indésirable médicamenteux, recensement prospectif dans un service d'urgence médicale. Raisons de Santé 23. Lausanne, Institut universitaire de médecine sociale et préventive, 1998.
13. Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 1992; 49 1696-700.
14. Raschetti R, Morgutti M, Menniti-Ippolito F; Belisari A, Rossignoli A, Longhini P, La Guidara C. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54:959-63.
15. Peterson JF, Bates DW. Preventable medication errors: Identifying and eliminating serious drug interactions. J Am Pharm Assoc (WAsh). 2001; 41:159-60.
16. Generali J. Avoiding drug interactions. Am Fam Physician 2000; 61:1628, 30, 37.
17. Nightingale PG, Adu D, Richards NT, Peters M. Implementation of rules based computerised bedside prescribing and administration: Intervention study. Br Med J 2000; 320:750-3.
18. Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, Burdick E, Hickey M, Kleefield S, Shea B, Vander Vliet M, Seger DL. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280:1311-16.
19. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: Results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58:648-64.
20. Johnson MT. Therapeutics ePocrates qRx 4.0. JAMA 2001; 286:229-30.
21. Barrett JR, Strayer SM, Schubart JR. Information needs of residents during inpatient and outpatient rotations: Identifying effective personal digital assistant applications. AMIA Annu Symp Proc 2003;784.
22. Sutton J, Stockton L, McCord G, Gilchrist VJ, Fedyna D. Handheld computer use in a family medicine clerkship. Acad Med 2004; 79 1114-19.
23. Clauson KA, Seamon MJ, Clauson AS, Van TB. Evaluation of drug information databases for personal digital assistants. Am J Health Syst Pharm 2004; 61:1015-24.
24. Robinson RL, Burk MS. Identification of drug-drug interactions with personal digital assistant-based software. Am J Med 2004; 116 357-8.
25. Barrons R. Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm 2004; 61:380-5.
26. Perkins NA, Murphy JE, Malone DC, Armstrong EP. Performance of drug-drug interaction software for personal digital assistants. Ann Pharmacother 2006; 40:850-5.
27. Rothschild JM, Lee TH, Bae T, Bates DW. Clinician use of a palmtop drug reference guide. J Am Med Inform Assoc 2002; 9:223-9.
28. Handbook of adverse drug interactions. New Rochelle NY, The Medical Letter, 2000.
29. Dukes MNG, Aronson JK. edn. Meyler's Side Effects of Drugs - An Encyclopedia of Adverse Reactions and Interactions, 14th edn. Amsterdam, Elsevier, 2000.
30. Hansten PD, Horn JR. Hansten and Hom's Drug Interactions Analysis and Management. Vancouver, Applied Therapeutics, 1997.
31. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17:857-72.
32. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44:763-70.
33. Dubach UC, Rosner B, Sturmer T. An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987). N Engl J Med 1991; 324 155-60.
34. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994; 331:1675-9.